SYNTAX试验参与国实践模式对5年预后的影响
SYNTAX试验在18个国家纳入1800例患者,其中8个入组≥80例的国家(美国245例、英国267例、意大利197例、法国208例、德国179例、荷兰148例、比利时91例、匈牙利83例)进入分析,其余国家患者合并为382例。5年结果显示各国临床结局存在显著差异,且血性心脏停搏液使用率、双侧乳内动脉使用率和非体外循环手术率等外科实践差异明显。
要点
- 法国PCI患者5年MACCE风险较低(HR=0.60,95%CI 0.37-0.98)。
- 匈牙利PCI患者再次血运重建率较高(HR=1.89,95%CI 1.14-3.42)。
- 英国CABG再次血运重建率最低(HR=0.32,95%CI 0.12-0.85)。
核心结论
- 各国患者特征与临床实践模式存在显著差异,导致5年结局显著不同。
- 本文提供具体数据,可帮助各国进一步改善结局。
研究设计与样本
- SYNTAX试验为随机对照试验,18个国家共纳入1800例患者。
- 8个入组≥80例的国家纳入分析,其余国家患者合并(n=382)。
主要发现
- PCI患者法国MACCE较低(HR=0.60,95%CI 0.37-0.98),匈牙利再次血运重建较高(HR=1.89,95%CI 1.14-3.42)。
- CABG再次血运重建率英国最低(HR=0.32,95%CI 0.12-0.85)。
- 血性心脏停搏液使用率3.1-89.0%(P<0.001),双侧乳内动脉使用率7.8-68.2%(P<0.001),非体外循环手术率3.9-44.4%(P<0.001)。
- PCI植入支架数4.0±2.3至6.1±2.6(P<0.001),支架总长度69.0±45.1至124.1±60.9 mm(P<0.001)。
- CABG术后阿司匹林79.6-95.0%(P=0.004)、噻吩吡啶6.8-31.1%(P<0.001)、他汀41.3-89.1%(P<0.001)。
关键数值与推荐
- 法国PCI患者MACCE的HR=0.60(95%CI 0.37-0.98)。
- 匈牙利PCI患者再次血运重建的HR=1.89(95%CI 1.14-3.42)。
- 英国CABG再次血运重建的HR=0.32(95%CI 0.12-0.85)。
临床怎么用
- 应关注本国与参与国在CABG技术(血性心脏停搏液、双侧乳内动脉、非体外循环)上的差距。
- 应重视CABG术后二级预防药物处方率的国别差异。
- 跨国实践差异提示需结合本国数据制定改进措施。
局限性
- 仅8个入组≥80例的国家单独分析,其余国家患者合并。
- 国家间比较属观察性分析,实践模式与结局的因果关系不能确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To examine differences among participating countries in baseline characteristics, clinical practice, medication strategies and outcomes of patients randomized to coronary artery bypass grafting and percutaneous coronary intervention in the SYNTAX trial. METHODS: In SYNTAX, centres in 18 different countries enrolled 1800 patients, of which 8 countries enrolled ≥80 patients, what was projected to be a large enough sample size to be included in the analysis. Baseline characteristics, practice patterns and clinical outcomes were compared between the USA (n = 245), the UK (n = 267), Italy (n = 197), France (n = 208), Germany (n = 179), Netherlands (n = 148), Belgium (n = 91) and Hungary (n = 83). The remaining patients from other participating countries were pooled together (n = 382). RESULTS: Five-year results demonstrated significantly different outcomes between countries. After adjustment, percutaneous coronary intervention patients in France had lower rates of major adverse cardiac and cerebrovascular events [hazard ratio (HR) = 0.60, 95% confidence interval (CI) 0.37-0.98], while the incidence of repeat revascularization was higher in Hungary (HR = 1.89, 95% CI 1.14-3.42). Coronary artery bypass grafting showed the lowest rate of repeat revascularization in the UK (HR = 0.32, 95% CI 0.12-0.85). There were numerous differences in the risk profile of patients between participating countries, as well as marked differences in surgical practice across countries in the use of blood cardioplegia (range 3.1-89.0%; P < 0.001), bilateral internal mammary artery usage (range 7.8-68.2%; P < 0.001) and off-pump procedures (range 3.9-44.4%; P < 0.001). Variation was also found for percutaneous coronary intervention in the number of implanted stents (range 4.0 ± 2.3 to 6.1 ± 2.6; P < 0.001) as well as for the entire stents length (range 69.0 ± 45.1 to 124.1 ± 60.9; P < 0.001). Remarkable differences were observed in the prescription of post-coronary artery bypass grafting medication in terms of acetylsalicylic acid (range 79.6-95.0%; P = 0.004), thienopyridine (6.8-31.1%; P < 0.001) and statins (41.3-89.1%; P < 0.001). CONCLUSIONS: Patient characteristics and clinical patterns are significantly different between countries, resulting in significantly different 5-year outcomes. This article presents specific data that can further improve outcomes in each country. CLINICAL TRIALS REGISTRY: NCT00114972.
引用
- Milojevic M, Head SJ, Mack MJ, et al. Influence of practice patterns on outcome among countries enrolled in the SYNTAX trial: 5-year results between percutaneous coronary intervention and coronary artery bypass grafting. Eur J Cardiothorac Surg. 2017. PMID: 28520861. doi:10.1093/ejcts/ezx104
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。